C39H37F2N7O8S — CID 156507668
2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]-3-fluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide (PubChem CID 156507668) has the molecular formula C39H37F2N7O8S and a molecular weight of 801.83 g/mol. Its IUPAC name is 2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]-3-fluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide.
| Compound Name | 2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]-3-fluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide |
|---|---|
| PubChem CID | 156507668 |
| Molecular Formula | C39H37F2N7O8S |
| Molecular Weight | 801.83 g/mol |
| Exact Mass | 801.24 |
| IUPAC Name | 2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]-3-fluoropiperidin-1-yl]-N-[5-fluoro-7-phenylmethoxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]acetamide |
| SMILES | Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(C3CCN(CC(=O)Nc4ccc5c(F)c(N6CC(=O)NS6(=O)=O)c(OCc6ccccc6)cc5c4)CC3F)cc21 |
| InChI | InChI=1S/C39H37F2N7O8S/c1-45-31-16-23(7-10-29(31)48(39(45)53)30-11-12-33(49)43-38(30)52)26-13-14-46(18-28(26)40)19-34(50)42-25-8-9-27-24(15-25)17-32(56-21-22-5-3-2-4-6-22)37(36(27)41)47-20-35(51)44-57(47,54)55/h2-10,15-17,26,28,30H,11-14,18-21H2,1H3,(H,42,50)(H,44,51)(H,43,49,52) |
| InChIKey | NAJOQMYIEIJNSG-UHFFFAOYSA-N |
| XLogP | 3.14 |
| TPSA | 181.15 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 57 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 801.83 |
| LogP ≤ 5 | 3.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|